Clinical commercialization of a clonal cell line - NK92

被引：0
|
作者：
Keller, G
Klingemann, H
Tonn, T
LeFever, A
Borys, M
Palazzolo, M
Domanik, R
机构：
[1] ZelleRx Corp, Chicago, IL USA
[2] St Lukes Med Ctr, Dept Immunotherapy, Aurora Healthcare, Milwaukee, WI USA
[3] Abbott Labs, Specialty Prod Div, N Chicago, IL 60064 USA
[4] Inst Transfus Med & Hematol, Red Cross Blood Donor Serv, Frankfurt, Germany
[5] IIT, Stuart Grad Sch Business, Chicago, IL 60616 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2003年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1α chain
    Yao, AY
    Tang, HY
    Wang, Y
    Feng, MF
    Zhou, RL
    CELL RESEARCH, 2004, 14 (02) : 155 - 160
  • [32] Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1α chain
    Ai Yu YAO
    Hai Yang TANG
    Yun WANG
    Mei Fu FENG
    Rou Li ZHOU
    Cell Research, 2004, 14 : 155 - 160
  • [33] Adoptive cellular immunotherapy in advanced cancer using the highly cytotoxic NK cell line NK-92.
    Tonn, T
    Esser, R
    Klingemann, HG
    Becker, S
    Bug, G
    Seidl, C
    Tam, YK
    Soerensen, J
    Koehl, U
    Bartling, T
    Hoelzer, D
    Seifried, E
    Ottmann, O
    Schwabe, D
    BLOOD, 1999, 94 (10) : 60B - 60B
  • [34] Release of granzyme B from NK92 cells which was crosslinking-stimulated by CD2
    Inoue, Hiroshi
    Uchihashi, Kenji
    Nishikawa, Yasuo
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S201 - S201
  • [35] Treatment of patients with advanced cancer with the natural killer cell line NK-92
    Tonn, Torsten
    Schwabe, Dirk
    Klingemann, Hans G.
    Becker, Sven
    Esser, Ruth
    Koehl, Ulrike
    Suttorp, Meinolf
    Seifried, Erhard
    Ottimann, Oliver G.
    Bug, Gesine
    CYTOTHERAPY, 2013, 15 (12) : 1563 - 1570
  • [36] Multicolor-FISH analysis of a natural killer cell line (NK-92)
    MacLeod, RAF
    Nagel, S
    Kaufmann, M
    Greulich-Bode, K
    Drexler, HG
    LEUKEMIA RESEARCH, 2002, 26 (11) : 1027 - 1033
  • [37] IL-18联合IL-2诱导NK92细胞的实验研究
    朱彬
    刘培淑
    宁辉
    周黎光
    山东大学学报(医学版), 2006, (10) : 1040 - 1044
  • [38] Effects of human leukocyte antigen-G1 on the recognition of NK92 effector-target cells
    Tian, XH
    Zhou, JJ
    Fang, ZF
    Lou, LL
    Wang, Y
    Feng, MF
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2002, 29 (06) : 904 - 909
  • [39] NK92细胞的胞吐效应与SNAP-23蛋白转位相关
    郑芳
    吴群
    姜小丹
    华中科技大学学报(医学版), 2005, (03) : 294 - 294
  • [40] 扶正化瘀方对NK92细胞活化和杀伤功能的影响
    平大冰
    孙鑫
    彭渊
    胡旭东
    陶艳艳
    刘成海
    中成药, 2021, (12) : 3310 - 3315
12345